Breaking Up Is Hard to Do: Omission of Radiation Therapy for Select Women Aged >70 Years With Breast Cancer

The goal of treatment for early-stage breast cancer is cure. Consecutive advances in local and systemic therapy have steadily improved cancer outcomes for patients with surgically resectable disease. When there is evidence that we can improve care by doing more, adoption of new interventions is relatively rapid. For example, within 3 years of the drug's US Food and Drug Administration approval, more than 92% of eligible locally advanced HER2-positive breast cancer patients had received adjuvant trastuzumab (1).

http://ift.tt/2s2vqLR